{"disease":{"id":"multi-drug-resistant","name":"multi drug resistant"},"drugs":{"marketed":[{"drug_id":"lenacapavir","indication_name":"Multidrug resistant HIV-1 infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sunlenca","generic_name":"LENACAPAVIR","company_name":"Gilead Sciences","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":58,"revenue":"1600","mechanism":"Sunlenca works by binding to a specific site on the HIV-1 protease, preventing the virus from replicating."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03349268","title":"Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection","phase":"NA","overall_status":"COMPLETED","enrollment_count":25732,"lead_sponsor_name":"University of Michigan","has_results":true},{"nct_id":"NCT02208154","title":"Ecological Effects of Decolonisation Strategies in Intensive Care","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":8665,"lead_sponsor_name":"MJM Bonten","has_results":false},{"nct_id":"NCT03360877","title":"Prevention of Nosocomial Infections (CleanKids)","phase":"NA","overall_status":"COMPLETED","enrollment_count":4944,"lead_sponsor_name":"Epicentre","has_results":false},{"nct_id":"NCT05200546","title":"Carbapenemase-Producing Organism and Vancomycin-Resistant Enterococcus Management","phase":"","overall_status":"COMPLETED","enrollment_count":3921,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT03303963","title":"DIAgnostics for Multidrug Resistant Tuberculosis in Africa","phase":"","overall_status":"COMPLETED","enrollment_count":3356,"lead_sponsor_name":"Dissou AFFOLABI","has_results":false},{"nct_id":"NCT03259269","title":"Expand New Drugs for TB [endTB]","phase":"","overall_status":"COMPLETED","enrollment_count":2804,"lead_sponsor_name":"Partners in Health","has_results":false},{"nct_id":"NCT05117788","title":"Bioneer Q-RFIA Clinical Evaluation","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2350,"lead_sponsor_name":"Foundation for Innovative New Diagnostics, Switzerland","has_results":false},{"nct_id":"NCT04388293","title":"Using Antibiotics Wisely - An Antimicrobial Stewardship Program","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT06391463","title":"Multi-resistant and Spore-forming Bacteria in a Neonatal Intensive Care Unit","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1500,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05081401","title":"Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1050,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT05871489","title":"Strengthening Evidence on Optimal Multidrug-resistant Tuberculosis Treatment Regimens","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":800,"lead_sponsor_name":"Harvard Medical School (HMS and HSDM)","has_results":false},{"nct_id":"NCT04239326","title":"Clinical Evaluation of tNGS for Diagnosis of DR-TB","phase":"","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"Foundation for Innovative New Diagnostics, Switzerland","has_results":false},{"nct_id":"NCT03728725","title":"Xpert MTB/XDR Clinical Evaluation Trial","phase":"","overall_status":"COMPLETED","enrollment_count":710,"lead_sponsor_name":"Foundation for Innovative New Diagnostics, Switzerland","has_results":false},{"nct_id":"NCT03827811","title":"Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis","phase":"","overall_status":"UNKNOWN","enrollment_count":625,"lead_sponsor_name":"University of Cape Town","has_results":false},{"nct_id":"NCT04421495","title":"Safety and Effectiveness of Delamanid-containing Regimen for MDR-TB Patients in China","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":608,"lead_sponsor_name":"Beijing Chest Hospital","has_results":false},{"nct_id":"NCT03830671","title":"The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":515,"lead_sponsor_name":"Beijing Chest Hospital","has_results":false},{"nct_id":"NCT01424670","title":"Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant Tuberculosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":511,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT04484129","title":"MDR-TB Close Contacts Tracing in China (TCCT Study)","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT03822156","title":"Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort","phase":"","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"University of Ulsan","has_results":false},{"nct_id":"NCT03604848","title":"NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TB","phase":"NA","overall_status":"UNKNOWN","enrollment_count":488,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT00685360","title":"A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":481,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT07017803","title":"Molecular Epidemiology, Strains Genotyping of Multi-drug Resistant Tuberculosis Circulating in Central Africa Region","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":460,"lead_sponsor_name":"Centre de Recherche Médicale de Lambaréné","has_results":false},{"nct_id":"NCT03338621","title":"Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":455,"lead_sponsor_name":"Global Alliance for TB Drug Development","has_results":true},{"nct_id":"NCT05824871","title":"A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Shanghai Jiatan Pharmatech Co., Ltd","has_results":false},{"nct_id":"NCT04014413","title":"Safety and Efficacy of Fecal Microbiota Transplantation","phase":"NA","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT04062201","title":"Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":402,"lead_sponsor_name":"Wits Health Consortium (Pty) Ltd","has_results":false},{"nct_id":"NCT05983861","title":"Risk Factors for Multidrug Resistant Bacteria at ICU Admission","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"José Raimundo Araujo de Azevedo","has_results":false},{"nct_id":"NCT05040126","title":"Modified BPaL Regimen for Managing Pre-XDR TB and MDR (TI/NR) TB in India","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Tuberculosis Research Centre, India","has_results":false},{"nct_id":"NCT07134270","title":"Infection Risk Associated With Digestive MDRO Carriage in Hospitalized Patients","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Valeriu Gheorghita","has_results":false},{"nct_id":"NCT03867136","title":"Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":354,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT04342598","title":"Case Control Study of Vitamin D Status and Adult Multidrug-resistant Pulmonary Tuberculosis in Maharashtra, India","phase":"","overall_status":"COMPLETED","enrollment_count":352,"lead_sponsor_name":"Harvard School of Public Health (HSPH)","has_results":false},{"nct_id":"NCT03896685","title":"Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":323,"lead_sponsor_name":"Médecins Sans Frontières, France","has_results":false},{"nct_id":"NCT07425561","title":"Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Azienda Ospedaliero-Universitaria Careggi","has_results":false},{"nct_id":"NCT06228248","title":"Antibiotics Resistance Gene in Healthcare Workers","phase":"","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT01933620","title":"Studies of the Human Microbiome in Clinical Center Patients","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":250,"lead_sponsor_name":"National Institutes of Health Clinical Center (CC)","has_results":false},{"nct_id":"NCT04081077","title":"PRACTECAL-PKPD Sub Study","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"Medecins Sans Frontieres, Netherlands","has_results":false},{"nct_id":"NCT04698148","title":"Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gastrointestinal Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":225,"lead_sponsor_name":"Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari","has_results":false},{"nct_id":"NCT06674291","title":"Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":222,"lead_sponsor_name":"Korea Otsuka Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT02573350","title":"A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":213,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT05306223","title":"A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":212,"lead_sponsor_name":"Beijing Chest Hospital","has_results":false},{"nct_id":"NCT03237182","title":"The Individualized M(X) Drug-resistant TB Treatment Strategy Study","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":205,"lead_sponsor_name":"Centre for the AIDS Programme of Research in South Africa","has_results":false},{"nct_id":"NCT03224169","title":"Implementation of Directly Observed Hand Hygiene in Residential Care Home for the Elderly: a Cluster Randomized Trial","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT01071603","title":"Tuberculosis in China","phase":"","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03086486","title":"Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":181,"lead_sponsor_name":"Global Alliance for TB Drug Development","has_results":true},{"nct_id":"NCT04397536","title":"New Genomic Techniques and Management of Multidrug-resistant Tuberculosis","phase":"","overall_status":"UNKNOWN","enrollment_count":172,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT02454205","title":"An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":154,"lead_sponsor_name":"University of Cape Town","has_results":false},{"nct_id":"NCT07206745","title":"A Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacterial Infections","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":152,"lead_sponsor_name":"Henan University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT07499505","title":"Hospital Effluents: a Health Monitoring Tool in the Era of Multi-resistance","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT01212003","title":"Training Protocol on the Natural History of Tuberculosis","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03470233","title":"Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB","phase":"","overall_status":"COMPLETED","enrollment_count":149,"lead_sponsor_name":"Korea Otsuka Pharmaceutical Co., Ltd.","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}